Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eli Lilly’s Alzheimer’s treatment shows promise in early stages of disease — but safety concerns remain By: MarketWatch July 17, 2023 at 10:15 AM EDT Drugmaker has completed its FDA submission for approval of donanemab, with regulatory action expected by the end of this year Read More >> Related Stocks: Biogen Idec Eisai Co. Ltd Eli Lilly Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Eli Lilly’s Alzheimer’s treatment shows promise in early stages of disease — but safety concerns remain By: MarketWatch July 17, 2023 at 10:15 AM EDT Drugmaker has completed its FDA submission for approval of donanemab, with regulatory action expected by the end of this year Read More >> Related Stocks: Biogen Idec Eisai Co. Ltd Eli Lilly